Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

US Patent 10466253 · Granted Nov 5, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Metabolic flux measurement, imaging and microscopy2019
Molecular flux rates through critical pathways measured by stable isotope labeli2017
Methods for determining total body skeletal muscle mass2017
Molecular flux rates through critical pathways measured by stable isotope labeli2017
Method for replacing biomarkers of protein kinetics from tissue samples by bioma2015
Molecular flux rates through critical pathways measured by stable isotope labeli2015
Molecular flux rates through critical pathways measured by stable isotope labeli2015
Method for automated, large-scale measurement of the molecular flux rates of the2015
Compositions and methods of treatment using modulators of motoneuron diseases2014
Molecular flux rates through critical pathways measured by stable isotope labeli2014
Monitoring two dimensions of diabetes pathogenesis2014
Method for high-throughput screening of compounds and combinations of compounds 2014